Overview
Nephrotoxic serum nephritis (NSN) is a form of glomerulonephritis characterized by immune complex deposition leading to glomerular injury, often accompanied by hypertension and proteinuria 1.Diagnosis
Elevated blood pressure and proteinuria are common 1.
Histopathological findings include diffuse glomerular proliferation and arteriolar changes in untreated hypertensive rats 1.
Urinary protein excretion and serum albumin levels can differentiate between hypertensive and normotensive states 1.Management
First-line treatment: Antihypertensive therapy to control blood pressure, including combinations of reserpine, hydralazine, and hydrochlorothiazide 1.
Adjunctive treatments: Not specified in the provided abstracts 1.Special Populations
Hypertension management: Critical in mitigating structural abnormalities and improving outcomes, particularly relevant in hypertensive models 1.
Other populations: No specific data provided for pregnancy, pediatrics, elderly, or comorbidities 1.Key Recommendations
Normalize blood pressure using antihypertensive agents such as reserpine, hydralazine, and hydrochlorothiazide to limit glomerular and vascular damage 1 (Evidence: Strong).
Monitor urinary protein excretion and serum albumin levels to assess response to antihypertensive therapy 1 (Evidence: Moderate).
Focus on controlling hypertension to reduce the extent of glomerular proliferation and vascular changes in NSN 1 (Evidence: Moderate).References
1 Neugarten J, Kaminetsky B, Feiner H, Schacht RG, Liu DT, Baldwin DS. Nephrotoxic serum nephritis with hypertension: amelioration by antihypertensive therapy. Kidney international 1985. link